[Drug resistance mechanism and new therapy strategy progression in targeted treatment of gastrointestinal stromal tumors].

Abstract excerpt

Gastrointestinal stromal tumors(GIST) are the most common mesenchymal tumors of the gastrointestinal tract. Most of these stromal tumors are characterized by mutations in the KTT or platelet-derived growth factor receptor α (PDGFRA) genes, resulting in the constitutive activation of tyrosine kinase signaling. Tyrosine kinase inhibitors(TKI), such as imatinib and sunitinib, provide the standard first-line and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Benzamides
• Share to Gastrointestinal Neoplasms